Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 2
2000 1
2001 2
2002 6
2003 2
2004 2
2005 1
2009 1
2010 2
2011 1
2012 4
2013 6
2014 1
2015 6
2016 3
2017 2
2018 5
2019 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Santin-Janin H, Mulder GJ, Bartholmai B, Gupta R, Richeldi L. Raghu G, et al. Among authors: van den blink b. JAMA. 2018 Jun 12;319(22):2299-2307. doi: 10.1001/jama.2018.6129. JAMA. 2018. PMID: 29800034 Free PMC article. Clinical Trial.
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L. Raghu G, et al. Among authors: van den blink b. Lancet Respir Med. 2019 Aug;7(8):657-664. doi: 10.1016/S2213-2600(19)30172-9. Epub 2019 May 20. Lancet Respir Med. 2019. PMID: 31122893 Clinical Trial.
[Idiopathic pulmonary fibrosis: new insights].
Kraan JW, van den Blink B, van den Toorn LM, Bresser P, van Beek FT, Grutters JC, Wijsenbeek MS. Kraan JW, et al. Among authors: van den blink b. Ned Tijdschr Geneeskd. 2015;159:A8148. Ned Tijdschr Geneeskd. 2015. PMID: 25654681 Review. Dutch.
Granuloma formation in pulmonary sarcoidosis.
Broos CE, van Nimwegen M, Hoogsteden HC, Hendriks RW, Kool M, van den Blink B. Broos CE, et al. Among authors: van den blink b. Front Immunol. 2013 Dec 10;4:437. doi: 10.3389/fimmu.2013.00437. Front Immunol. 2013. PMID: 24339826 Free PMC article. Review.
Serum biomarkers in idiopathic pulmonary fibrosis.
van den Blink B, Wijsenbeek MS, Hoogsteden HC. van den Blink B, et al. Pulm Pharmacol Ther. 2010 Dec;23(6):515-20. doi: 10.1016/j.pupt.2010.08.001. Epub 2010 Aug 12. Pulm Pharmacol Ther. 2010. PMID: 20708704 Review.
Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes.
Broos CE, Koth LL, van Nimwegen M, In 't Veen JCCM, Paulissen SMJ, van Hamburg JP, Annema JT, Heller-Baan R, Kleinjan A, Hoogsteden HC, Wijsenbeek MS, Hendriks RW, van den Blink B, Kool M. Broos CE, et al. Among authors: van den blink b. Eur Respir J. 2018 Mar 1;51(3):1701124. doi: 10.1183/13993003.01124-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29449421 Free article.
Enhanced Bruton's tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis.
Heukels P, van Hulst JAC, van Nimwegen M, Boorsma CE, Melgert BN, von der Thusen JH, van den Blink B, Hoek RAS, Miedema JR, Neys SFH, Corneth OBJ, Hendriks RW, Wijsenbeek MS, Kool M. Heukels P, et al. Among authors: van den blink b. Respir Res. 2019 Oct 24;20(1):232. doi: 10.1186/s12931-019-1195-7. Respir Res. 2019. PMID: 31651327 Free PMC article.
Study of calcium signaling in non-excitable cells.
Van Den Brink GR, Bloemers SM, Van Den Blink B, Tertoolen LG, Van Deventer SJ, Peppelenbosch MP. Van Den Brink GR, et al. Among authors: van den blink b. Microsc Res Tech. 1999 Sep 15;46(6):418-33. doi: 10.1002/(SICI)1097-0029(19990915)46:6<418::AID-JEMT9>3.0.CO;2-0. Microsc Res Tech. 1999. PMID: 10504218 Review.
46 results